Bendroflumethiazide tablet and preparation method thereof

Benfluflumethiazide tablets and Benfluflumethiazide technology, which are applied in the field of Benfluflumethiazide tablets and their preparation, can solve problems such as content differences among bendrofluthiazide tablets, and achieve easy industrialized large-scale production and preparation processes Simple, fast-dissolving results

Inactive Publication Date: 2017-07-14
HUAYI PHARMA ANHUI CO LTD
1 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0009] The invention provides a bendrofluthiazide tablet and a preparation method thereof, which solves...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Abstract

The invention discloses a bendroflumethiazide tablet and a preparation method thereof and belongs to the technical field of medicine preparations. The bendroflumethiazide tablet is composed of, by weight, 0.25-0.5 parts of bendroflumethiazide, 2-6 parts of microcrystalline cellulose PH-102, 4-8 parts of lactose, 0.2-0.6 parts of carboxymethyl starch sodium, and 0.02-0.04 parts of magnesium stearate. The preparation method of the bendroflumethiazide tablet includes the steps of: performing air jet pulverization to the bendroflumethiazide; uniformly mixing the bendroflumethiazide, microcrystalline cellulose PH-102 and magnesium stearate to obtain a mixture material; adding the lactose and carboxymethyl starch sodium to the mixture material, and uniformly mixing the materials; and performing dry-method direct tabletting to obtain the bendroflumethiazide tablet. The bendroflumethiazide tablet is more homogenous in content of bendroflumethiazide and is more rapidly to dissolve out in 5 min. The preparation method is simple, wherein the auxiliary materials, except the microcrystalline cellulose PH-102, are free of special pulverization treatment. The preparation method is free of complex preparation devices and is easy to achieve in industrial production.

Application Domain

Technology Topic

Image

  • Bendroflumethiazide tablet and preparation method thereof

Examples

  • Experimental program(5)
  • Effect test(1)

Example Embodiment

[0025] Example 1
[0026] This embodiment provides a benzylfluorothiazide tablet, which is composed of the following components in parts by weight: benzylfluorothiazide 0.25Kg, microcrystalline cellulose PH-102 4Kg, lactose 6Kg, sodium starch glycolate 0.4Kg, hard Magnesium fatty acid 0.03Kg.
[0027] The preparation method of the above benzylfluorothiazide tablets includes the following steps:
[0028] (1) Air jet pulverization of benzylfluorothiazide, air jet pulverization control D90 = 30-60 microns;
[0029] (2) Take benzylfluorothiazide, microcrystalline cellulose PH-102 and magnesium stearate and mix uniformly to obtain a mixture;
[0030] (3) Add lactose and sodium starch glycolate to the mixture and mix well;
[0031] (4) Adopting dry method to directly compress tablets, the batch size is 100,000 tablets, and the tablet specification is 2.5mg/tablet.

Example Embodiment

[0032] Example 2
[0033] This embodiment provides a benzylfluorothiazide tablet, which is composed of the following components in parts by weight: benzylfluorothiazide 0.25Kg, microcrystalline cellulose PH-102 6Kg, lactose 4Kg, sodium starch glycolate 0.6Kg, hard Magnesium fatty acid 0.02Kg.
[0034] The preparation method of the above benzylfluorothiazide tablets includes the following steps:
[0035] (1) Air jet pulverization of benzylfluorothiazide, air jet pulverization control D90 = 30-60 microns;
[0036] (2) Take benzylfluorothiazide, microcrystalline cellulose PH-102 and magnesium stearate and mix uniformly to obtain a mixture;
[0037] (3) Add lactose and sodium starch glycolate to the mixture and mix well;
[0038] (4) Adopting dry method to directly compress tablets, the batch size is 100,000 tablets, and the tablet specification is 2.5mg/tablet.

Example Embodiment

[0039] Example 3
[0040] This embodiment provides a benzylfluorothiazide tablet, which is composed of the following components in parts by weight: benzylfluorothiazide 0.25Kg, microcrystalline cellulose PH-102 2Kg, lactose 8Kg, sodium starch glycolate 0.2Kg, hard Magnesium fatty acid 0.04Kg.
[0041] The preparation method of the above benzylfluorothiazide tablets includes the following steps:
[0042] (1) Air jet pulverization of benzylfluorothiazide, air jet pulverization control D90 = 30-60 microns;
[0043] (2) Take benzylfluorothiazide, microcrystalline cellulose PH-102 and magnesium stearate and mix uniformly to obtain a mixture;
[0044] (3) Add lactose and sodium starch glycolate to the mixture and mix well;
[0045] (4) Adopting dry method to directly compress tablets, the batch size is 100,000 tablets, and the tablet specification is 2.5mg/tablet.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Similar technology patents

Classification and recommendation of technical efficacy words

  • Uniform content
  • Promote dissolution

Method for doping silicon-based film by eutectic growth

InactiveCN102560400AUniform contentSimple equipmentVacuum evaporation coatingSputtering coatingIonHot filament
Owner:GRADUATE SCHOOL OF THE CHINESE ACAD OF SCI GSCAS

Bilayer tablet comprising telmisartan and amlodipine

InactiveCN101052381APromote dissolutionFix stability issuesOrganic active ingredientsNervous disorderAngiotensin 2 Receptor BlockerAngiotensin II receptor antagonist
Owner:BOEHRINGER INGELHEIM INT GMBH

Limestone-gypsum wet desulfurization additive

InactiveCN102847428APromote SO2 dissolutionPromote dissolutionDispersed particle separationGypsumOrganic acid (substance)
Owner:SNTO TECH GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products